Clinical Implications The growing prevalence of GLP-1 receptor agonist and dual incretin agonist use necessitates increased awareness among anesthesiologists, surgeons, gastroenterologists, endocrinologists, primary care clinicians, and perioperative nursing teams
By emphasizing sustainable lifestyle changes, we empower you to maintain weight loss progress for years to come
While uncomfortable, this side effect is typically temporary and manageable
Although empagliflozin appeared to have less of a reno-protective effect in patients with HFpEF than with HFrEF, further analyses of EMPEROR-Preserved indicate that this may be related to the endpoint definition used (which excluded renal death and included 40% decrease in eGFR), with positive findings when using the renal endpoint from the DAPA-HF trial (which included renal death and 50% decrease in eGFR) [130, 131]
I didnt feel any different